Similar articles

• Effect of clofibrate on arginine-stimulated glucagon and insulin secretion in man.

  Eaton RP, Schade DS. Eaton RP, et al. Metabolism. 1974 May;23(5):445-54. doi: 10.1016/0026-0495(74)90092-4. Metabolism. 1974. PMID: 4825301 No abstract available.
• Glucagon secretion in primary endogenous hypertriglyceridemia before and after clofibrate treatment.

  Tiengo A, Muggeo M, Assan R, Fedele D, Crepaldi G. Tiengo A, et al. Metabolism. 1975 Aug;24(8):901-14. doi: 10.1016/0026-0495(75)90081-5. Metabolism. 1975. PMID: 1143089
• [Blood levels of glucagon, insulin and nonesterified fatty acids after arginine stimulation in obese diabetics].

  Cucinotta D, Quartarone M, Saitta A, Sardo A, Squadrito G. Cucinotta D, et al. Boll Soc Ital Biol Sper. 1978 Nov 30;54(22):2290-6. Boll Soc Ital Biol Sper. 1978. PMID: 754729 Italian. No abstract available.
• [Active chronic hepatitis and insulin resistance: possible role of glucagon, GH and free fatty acids].

  Bonora E, Coscelli C, Orioli S, Cambi R, Buzzelli G, Gentilini P, Butturini U. Bonora E, et al. G Clin Med. 1981 Dec;62(12):831-45. G Clin Med. 1981. PMID: 7042433 Review. Italian. No abstract available.
• Glucagon and lipoproteins.

  Eaton RP. Eaton RP. Metabolism. 1976 Nov;25(11 Suppl 1):1415-7. doi: 10.1016/s0026-0495(76)80154-0. Metabolism. 1976. PMID: 790087 Review. No abstract available.